• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Charles River Laboratories Intl (NY: CRL )

    187.16 +4.68 (+2.56%)
    Streaming Delayed Price Updated: 10:10 AM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Charles River Laboratories Intl

    < Previous 1 2
    ...
    6 7 8 9 10 11 12 13 Next >
    Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Bragar Eagel & Squire, P.C. Is Investigating Fox, Norfolk Southern, Charles River, and CCSI and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, LEADING INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Law Enforcement Supply Chain
    Exposures Legal Supply Chain
    Why Charles River Stock Is Plunging Today
    Via Benzinga
    Charles River Dives As Monkey Investigation Hamstrings 2023 Outlook
    The DOJ is investigating shipments of nonhuman primates from Cambodia. 
    Via Investor's Business Daily
    This Favorable Sign Appears On Charles River's Chart
    Via Benzinga
    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Law Enforcement Supply Chain
    Exposures Legal Supply Chain
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    $39M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
    Although US stocks closed lower on Friday, there were a few notable insider trades. 
    Via Benzinga
    ROSEN, NATIONAL TRIAL COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - CRL
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Law Enforcement Supply Chain
    Exposures Legal Supply Chain
    CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Charles River Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Investigation
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    CRL EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors With Losses In Excess of $100K to Inquire About Securities Class Action Investigation – CRL
    From The Rosen Law Firm, P.A.
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
    Via Benzinga
    INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Charles River Laboratories International, Inc. and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Charles River Laboratories International, Inc. and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Launches Novel IgY-based ELISA Kit for the Detection and Quantitation of Residual Host Cell Protein
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Jim Cramer Says This Stock Is Undervalued: 'I Think That It's Coming Back'
    On CNBC’s "Mad Money Lightning Round," Jim Cramer he wants to own Sherwin-Williams Co (NYSE: SHW). "Everything that they could possibly say negative about it is out there. 
    Via Benzinga
    Charles River Laboratories Acquires SAMDI Tech
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories, AbbVie, Star Bulk Carriers And This Big Bank Are CNBC's 'Final Trades'
    On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said Charles River Laboratories International, Inc. (NYSE: CRL) is trading at 20 time 
    Via Benzinga
    Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
    From Charles River Laboratories International, Inc.
    Via Business Wire
    < Previous 1 2
    ...
    6 7 8 9 10 11 12 13 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.